ONdrugDelivery

Published online: "REVOLUTIONISING EYE CARE: THE POTENTIAL OF ANTISENSE OLIGONUCLEOTIDES". Read the full ONdrugDelivery article 👉 https://lnkd.in/eBSYDgc5 "Binbin Tian of WuXi AppTec discusses antisense oligonucleotides and considers their potential as treatments for genetic and multifactorial ophthalmic diseases previously considered untreatable. The article considers how these therapies function as treatments, their current state of development, challenges in their delivery and the evolving regulatory landscape."

Published online: "GENE THERAPY IN OPHTHALMOLOGY: ADVANCES AND CHALLENGES". Read the full ONdrugDelivery article 👉 https://lnkd.in/e6dG7sTC "Joe Batley and Lorna Barron of Springboard Pro, A Sanner Group Company provide an overview of the latest cutting-edge ophthalmic delivery methods and discuss possible future developments."

Published online: "A COMPREHENSIVE APPROACH TO ADDRESSING UNMET NEEDS IN INTRAVITREAL INJECTIONS". Read the full ONdrugDelivery article 👉 https://lnkd.in/eanNEFHV "Reza Abedian, phD, Marie Stockton and Bernd Zeiß consider the complexities and clinical unmet needs of intravitreal injections and discuss how Gerresheimer’s syringe technology can help overcome these challenges."

Published online: "GLAUCOMA IN VIEW: IMPROVING PATIENT ADHERENCE WITH MULTIDOSE EYEDROPPERS FOR PRESERVATIVE-FREE SOLUTIONS". Read the full ONdrugDelivery article 👉 https://lnkd.in/ex67trw4 "Zoë D. considers the impact of glaucoma on global health and the challenges presented by its increasing prevalence in the ageing global population, discussing how Novelia®, NEMERA’s multidose eyedropper for preservative-free formulations, is well-positioned to address many of the challenges presented by glaucoma treatments, from ease of use to sustainability."

Published online: "A NEW DELIVERY PLATFORM FOR SUPRACHOROIDAL ADMINISTRATION USING WEST’S ADVANCEABLE MICRONEEDLE DEVICE". Read the full ONdrugDelivery article 👉 https://lnkd.in/edeP7MXa "Anu Prabhathachandran, Menachem Peretz and Manali P. discuss the growing need for more effective delivery of therapeutics to treat ophthalmic conditions to meet the needs of the ageing population, including how delivery into the suprachoroidal space may present an appealing alternative to intravitreal injection. The authors go on to introduce West Pharmaceutical Services’ Suprachoroidal Advanceable Microneedle Device, which offers several advantages for overcoming the challenges with suprachoroidal space."

ONdrugDelivery undoubtedly has the best content out there for 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 & 𝐏𝐡𝐚𝐫𝐦𝐚 𝐏𝐚𝐜𝐤𝐚𝐠𝐢𝐧𝐠. If you're living under a rock and haven't heard of them yet, please check them out. Also, read this interesting article on 𝐃𝐫𝐮𝐠 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐲 𝐓𝐫𝐞𝐧𝐝𝐬 𝐟𝐨𝐫 2025 where they discuss: - 𝑬𝒎𝒆𝒓𝒈𝒆𝒏𝒄𝒚 𝑪𝒐𝒎𝒃𝒊𝒏𝒂𝒕𝒊𝒐𝒏 𝑷𝒓𝒐𝒅𝒖𝒄𝒕𝒔 - 𝑹𝒆𝒖𝒔𝒂𝒃𝒍𝒆 𝑫𝒓𝒖𝒈 𝑫𝒆𝒍𝒊𝒗𝒆𝒓𝒚 𝑫𝒆𝒗𝒊𝒄𝒆𝒔 - 𝑹𝒆𝒏𝒆𝒘𝒆𝒅 𝑰𝒏𝒕𝒆𝒓𝒆𝒔𝒕 𝒊𝒏 𝑮𝒂𝒔-𝑷𝒐𝒘𝒆𝒓𝒆𝒅 𝑰𝒏𝒋𝒆𝒄𝒕𝒐𝒓𝒔 - 𝑹𝒆𝒅𝒖𝒄𝒆𝒅 𝑰𝒏𝒋𝒆𝒄𝒕𝒊𝒐𝒏 𝑺𝒊𝒕𝒆 𝑷𝒂𝒊𝒏 Very insightful article by Tom Oakley and Iskandar Vasiev from Springboard Pro, A Sanner Group Company https://lnkd.in/evDYeBNt

Heads Up, friends 👀 ! Your Early Bird discount ends in less than 48 hours for our Combination Products Summit 2025. Join your colleagues in Philadelphia for this can't-miss networking and learning opportunity. Want to attend? Claim your discount today at www.pharmaedresources.com Hope to see you there! #CombinationProducts #DrugDelivery #MedDevices #PharmEdEvents

The latest ONdrugDelivery is out! - Issue 169, Mar 2025, focuses 100% on "OPHTHALMIC DRUG DELIVERY" from cover-to-cover. Read it here 👉 https://lnkd.in/egmGz9JW Gerresheimer opens the issue with an article on intravitreal injection. The article features an in-depth consideration of the role that intravitreal injections play in treating retinal diseases and the challenges associated with current delivery methods. In particular, Gerresheimer tackles the critical need for silicone-oil-free syringes in this space and discusses the findings of the company’s research into this topic. Next, West Pharmaceutical Services discuss injection into the suprachoroidal space, an alternative minimally invasive but challenging route for delivery of ocular treatments. West’s article introduces the company’s Suprachoroidal Advanceable Microneedle Device, aimed at facilitating this delivery method and mitigating some of the difficulties associated with administration to the suprachoroidal space. The article includes discussion of a directional study West conducted in late 2024 on the effectiveness of the device to these ends.   Following these articles, WuXi AppTec and Springboard Pro, A Sanner Group Company each share an Expert View on the progress of gene and cell therapies in the ophthalmic sector. WuXi AppTec focuses on the potential of antisense oligonucleotides for treating genetic and multifactorial ocular diseases, discussing both the benefits and challenges these therapies could bring. Springboard, meanwhile, offers a broader perspective on cell and gene therapies in ophthalmology, considering the emerging clinical pipeline and how various drug developers will deliver these novel drugs, before looking to the future of these therapies in the sector.   To conclude the issue, NEMERA features an article on ongoing efforts to optimise the treatment of glaucoma. Nemera’s article covers the need for safe, preservative-free eye drops to meet the self-administration needs of patients, and how the company’s Novelia eyedropper is a well-established solution to meet this need. The article explores how Novelia supports patient needs while also meeting sustainability demands in the eyedropper market. We would also like to thank Credence MedSystems Inc and Nipro Corporation - Global for sponsoring this issue. Access the full issue's content here 👉 https://lnkd.in/egmGz9JW

ONdrugDelivery is pleased to be a Media Partner for Medical Technology UK again for 2025. 📅 12-13 March 2025 📍 Coventry Building Society Arena, Coventry UK 🔗 Free registration & more info: https://lnkd.in/enNWk7M The event brings together companies involved in the design, development, and production of medical devices, with 100+ exhibitors from across the supply chain. Alongside the exhibition, the Learning Programme will feature industry speakers covering innovation, regulatory challenges, and business resilience in MedTech. This year’s agenda includes: 🔹 "The Future of Medical Technology Innovation" – chaired by Karen Taylor (Deloitte Insights) 🔹 "Disruptive Innovators in MedTech" – exploring resilience and productivity 🔹 "Bringing New Medical Devices to Market" – insights into regulatory pathways and development challenges Details in the press release attached to this post. We are looking forward to catching up with industry colleagues in Coventry in two weeks' time! #MedicalTechUK #MedTech #MedicalDevices #drugdelivery

Published online: "OPTIMISING CLINICAL TRIALS WITH AUTOINJECTORS: STRATEGIES FOR SUCCESS". Read the full ONdrugDelivery article 👉 https://lnkd.in/dVcxcH-K "William Welch of PCI Pharma Services discusses the key considerations for integrating autoinjectors into clinical trial programmes, and the myriad benefits that doing so can bring for trial sponsors in terms of standardisation, data quality and patient-centricity."